Some patients with stage II highly differentiated endometrial cancer can achieve clinical cure, but there is still the possibility of recurrence. Actively adopting surgical treatment, radiotherapy and chemotherapy is conducive to slowing down the progression of the disease and improving the prognosis.
1. Surgery: patients with stage II highly differentiated endometrial cancer who can tolerate surgery should undergo extensive hysterectomy and bilateral pelvic lymph node and para-abdominal aortic lymph node dissection.
2. Radiation therapy: according to the size of lesions, intracavitary irradiation or extracorporeal irradiation can be added before extensive hysterectomy. It is recommended that surgery be performed within 1-2 weeks after the end of intracavitary radiotherapy and 4 weeks after the end of extracorporeal irradiation.
3. Chemotherapy: if patients with stage II highly differentiated endometrial cancer cannot tolerate surgery or have recurrence after treatment, chemotherapy can be considered, commonly used drugs include adriamycin, fluorouracil, cyclophosphamide, mitomycin, etc. Specific chemotherapy plan depends on patient’s condition, and the drugs should be administered according to doctor’s prescription.
After comprehensive treatment, it is favorable to improve the prognosis. It is recommended to monitor the physical condition during the treatment period, consult the doctor promptly if there is any discomfort, and actively treat the symptoms.